The size of the Europe Ablation Technologies market has been calculated at USD 1107.65 Million in 2022 and is projected to reach USD 1884.18 Million by 2027, growing at a CAGR of 11.21% between 2022 to 2027.
Ablation is removing material from the surface of an object by chipping, vaporization, or other erosive processes. Medical ablation is the treatment that destroys tumors or unwanted material without affecting other body tissues or organs. In treating chronic diseases, medical ablation plays a prime role in removing or destroying abnormal tissue.
The market for Ablation Technologies is mainly driven due to recent technological advancements and studies, the ever-increasing incidence of cancer and cardiac disease population, increasing demand for ablation technologies, recent developments that have led to reduced healthcare costs, and improvement in the patient quality of life.
But the market growth can be restrained due to a stringent regulatory framework leading to an increase in the gestation period for product launches.
This research report on the Europe Ablation Technologies Market has been segmented and sub-segmented into the following categories.
Based on type, the Radiofrequency-based ablation technology segment is expected to lead the European ablation technologies market.
Based on application, a large market share is attributed to the cardiovascular disease treatment segment.
Based on region, Europe is the second biggest market in market share across the globe. The market in Europe is highly driven by ongoing technological advancements in ablation devices, which have given the world a wide range of products that have assured safety and efficacy for the consumers.
Prominent Companies leading the Europe Ablation Technologies Market Profiled in the Report are Biosense Webster, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, AngioDynamics, Inc., AtriCure, Inc., Smith & Nephew plc, Galil Medical Inc., CONMED Corporation, Olympus Corporation, Covidien PLC, Medtronic, Inc., and BSD Medical Corporation.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Light/Laser ablators
188.8.131.52 Excimer laser ablators
184.108.40.206 Cold laser ablators
5.1.3 Radiofrequency (RF) ablators
220.127.116.11 Temperature-controlled RF ablators
18.104.22.168 Fluid-cooled RF ablators
22.214.171.124 Robotic catheter manipulation systems
5.1.4 Electrical ablators
126.96.36.199 Argon plasma/beam coagulators
188.8.131.52 Irreversible electroporation ablators
5.1.5 Ultrasound ablators
184.108.40.206 High-intensity focused ultrasound (HIFU) ablators
220.127.116.11 Magnetic resonance guided focused ultrasound (MRGFUS) ablators
18.104.22.168 Ultrasonic surgical ablation systems
22.214.171.124 Extracorporeal shockwave lithotripsy systems
5.1.6 Microwave ablators
126.96.36.199 Microwave thermotherapy ablators
5.1.7 Cryoablation devices
188.8.131.52 Tissue contact probe ablators
184.108.40.206 Tissue spray probe ablators
220.127.116.11 Epidermal and subcutaneous cryoablation systems
5.1.8 Hydrothermal ablators
18.104.22.168 Endothermal hydrothermal balloon ablation devices
5.1.9 Y-o-Y Growth Analysis, By Product
5.1.10 Market Attractiveness Analysis, By Product
5.1.11 Market Share Analysis, By Product
5.2.2 Light/Laser Ablation
5.2.3 Radiofrequency Ablation
5.2.4 Electrical Ablation
5.2.5 Ultrasound Ablation
5.2.7 Microwave Ablation
5.2.8 Hydrothermal Ablation
5.2.9 Y-o-Y Growth Analysis, By Type
5.2.10 Market Attractiveness Analysis, By Type
5.2.11 Market Share Analysis, By Type
5.3.2 Cardiovascular Disease Treatment
5.3.3 Cancer Treatment
5.3.4 Ophthalmologic Treatment
5.3.5 Gynecologic Treatment
5.3.6 Pain Management
5.3.7 Urologic Treatment
5.3.8 Orthopedic Treatment
5.3.9 Cosmetic Surgery
5.3.10 Other Treatments
5.3.11 Y-o-Y Growth Analysis, By Application
5.3.12 Market Attractiveness Analysis, By Application
5.3.13 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Product
188.8.131.52 By Type
184.108.40.206 By Application
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Product
22.214.171.124 By Type
126.96.36.199 By Application
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Type
18.104.22.168 By Application
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Biosense Webster, Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 St. Jude Medical, Inc.
8.3 Boston Scientific Corporation
8.4 AngioDynamics, Inc.
8.5 AtriCure, Inc.
8.6 Smith & Nephew plc
8.7 Galil Medical Inc.
8.8 CONMED Corporation
8.9 Olympus Corporation
8.10 Covidien PLC
8.11 Medtronic, Inc.
8.12 BSD Medical Corporation
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.